Related Experiment Video
Updated: Aug 2, 2026
09:09
Ischemia-reperfusion Model of Acute Kidney Injury and Post Injury Fibrosis in Mice
Published on: August 9, 2013
Impaired IL-18 processing protects caspase-1-deficient mice from ischemic acute renal failure
V Y Melnikov1, T Ecder, G Fantuzzi
1Department of Medicine, University of Colorado School of Medicine, Denver, Colorado 80262, USA.
The Journal of Clinical Investigation
|May 9, 2001
Summary
Mice lacking caspase-1 (a protein that activates IL-18) showed reduced kidney damage from ischemic acute renal failure (ARF). Blocking IL-18 also protected against ARF, suggesting IL-18 contributes to kidney injury.
Area of Science:
- Renal Physiology
- Inflammation Biology
- Molecular Medicine
Background:
- Ischemic acute renal failure (ARF) is a significant clinical challenge.
- The role of inflammatory mediators like caspase-1 and IL-18 in ARF pathogenesis is not fully understood.
Purpose of the Study:
- To investigate the protective effect of caspase-1 deficiency against ischemic ARF in mice.
- To determine the contribution of IL-18 to the development of ischemic ARF.
Main Methods:
- Comparison of renal function and histology in caspase-1 deficient (caspase-1(-/-)) mice versus wild-type mice subjected to ischemic ARF.
- Measurement of blood urea nitrogen (BUN) and serum creatinine levels.
- Assessment of IL-18 precursor to mature form conversion in kidney tissue.
- Administration of IL-18 neutralizing antiserum to wild-type mice prior to ischemic insult.
- Evaluation of myeloperoxidase (MPO) activity and neutrophil infiltration in kidney tissue.
Main Results:
- Caspase-1(-/-) mice exhibited significantly reduced renal dysfunction and histological damage compared to wild-type mice following ischemic ARF.
- ARF induced a marked increase in kidney IL-18 levels and processing of its precursor in wild-type mice, which was absent in caspase-1(-/-) mice.
- Neutralization of IL-18 provided similar protection against ARF as observed in caspase-1(-/-) mice.
- Myeloperoxidase activity and neutrophil infiltration were significantly reduced in both caspase-1(-/-) and IL-18 antiserum-treated mice.
Conclusions:
- Caspase-1 deficiency confers protection against ischemic ARF.
- IL-18 plays a critical role in the development of ischemic ARF, potentially mediated through increased neutrophil infiltration.
- Targeting the caspase-1/IL-18 pathway may represent a therapeutic strategy for preventing or treating ischemic ARF.
Related Concept Videos
01:24Caspases
Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...